Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Zhang T, Kutler D, Scognamiglio T, Gudas LJ, Tang X-. Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongue. Discov Oncol. 2023;14(1):24.

Metzler VM, de Brot S, Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, et al. The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. Front Cell Dev Biol. 2023;11:1116424.

Santo EE, Ribel-Madsen R, Stroeken PJ, de Boer VC, Hansen NS, Commandeur M, et al. FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity. Aging Cell. 2023;22(3):e13763.

Schreidah CM, Fahmy LM, Lapolla BA, Kwinta BD, Magro CM, Geskin LJ. Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. Am J Dermatopathol. 2023;45(8):572-576.

Geyer JT, Kluk MJ. Current Landscape of Ancillary Diagnostic Testing in Chronic Lymphocytic Leukemia. Surg Pathol Clin. 2023;16(2):411-421.

Vidotto T, Imada EL, Faisal F, Murali S, Mendes AA, Kaur H, et al. Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer. JCI Insight. 2023;8(3).

Sigel C, Wei X-, Agaram N, Sigel K, Raza R, Andrade R, et al. Diagnostic features of low- and high-grade mucinous neoplasms in pancreatic cyst FNA cytology. Cancer Cytopathol. 2023;131(5):325-336.

Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, et al. Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas. Cancer Cell. 2023;41(6):1198.

Boyraz B, Paula AD, Deveraux KA, Tran I, da Silva EM, Young RH, et al. Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and CTNNB1 Translocation : A Report of 3 Cases. Am J Surg Pathol. 2023;47(11):1285-1290.

Liu W, Newhall KP, Khani F, Barlow LM, Nguyen D, Gu L, et al. The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer. Cancer Res. 2023;83(4):506-520.